Litigation Watch: ARTHRITIS DRUGS is a monthly newsletter for attorneys, focusing on drugs used to treat osteo and rheumatoid arthritis: Arava, Enbrel, Remicade, Humira, Vioxx, Celebrex and more. These drugs are already the subject of litigation following claims that they cause everything from liver damage to cancer, heart failure and strokes. Each issue features case news, interviews, legislative and FDA updates, and reviews from current medical literature.
Arthritis Drugs - Issue: 15
Briefs Exchanged in Jurisdictional Battle over Twice-Removed Vioxx Case
New Jersey Vioxx Judge Certifies Third Party Payor Class
Louisiana Plaintiffs Move for Class Certification of Bextra Case
MDL Judge Modifies Order to Allow Certain Ex Parte Communications with Physicians
Judge Says Merck 'Vioxx Alternative' Document Privileged, Orders It Returned
Arthritis Drugs - Issue: 14
Arthritis Drugs In the Medical Literature This Month
Canadian Panel Recommends Return of Vioxx
Court Stays Vioxx Case Despite Recent Rulings on Motions to Remand
